Biodistribution of Radiolabeled Nanomaterials
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : King's College London, Centre de Biophysique Moléculaire, Queen Mary University of London
Variable analysis
- 111In-labelled L2/3
- L2/3:ox-MWNTs
- L2/3:ox-MWNTs-NH3+
- Biodistribution of 111In-labelled compounds
- Injection of 100 μg of labelled 111In(L2/3):f-MWNTs (1 mg/ml in PBS) or In(L2/3) alone (100 μg) under isoflurane anaesthesia
- SPECT/CT scans carried out on the same animal at multiple time points: immediately after injection, at 4 h and 24 h
- Mice placed in the prone position for SPECT scans acquired over 24 projections (60 s per projection), using a 4-head scanner with 1.4 mm pinhole collimators, for a total acquisition time of 30-40 min
- CT scans (45 kVP X-ray) performed after each SPECT
- Positive control: 111In(L2/3):f-MWNTs
- Negative control: In(L2/3) alone
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!